Semangat pagi Pak Syafril..

Ada Header email sbb di SPAM TRAP Queue:
X-MDAV-Processed: bb.ptbmi.com, Wed, 12 Dec 2018 21:54:15 +0700
Return-path: <[email protected]>
Authentication-Results: bb.ptbmi.com;
   spf=pass [email protected];
dkim=pass (good signature) header.d=info.fda.gov header.b=0TynUUJBsd [email protected];
   dmarc=pass header.from=info.fda.gov (p=reject sampling=82 pct=100);
   iprev=pass policy.iprev=129.145.17.215 (PTR eloquamail01.fda.gov);
   iprev=pass policy.iprev=129.145.17.215 (HELO eloquamail01.fda.gov);
iprev=fail policy.iprev=129.145.17.215 reason="does not match" (MAIL [email protected])
Received-SPF: pass (bb.ptbmi.com: domain info.fda.gov
   designates 129.145.17.215 as permitted sender)
   receiver=bb.ptbmi.com; client-ip=129.145.17.215;
   mechanism=ip4:129.145.17.0/24; envelope-from="[email protected]";
   helo=eloquamail01.fda.gov;
Received: from eloquamail01.fda.gov (eloquamail01.fda.gov [129.145.17.215]) by bb.ptbmi.com (MDaemon PRO v18.5.1)
   with ESMTPS id 46-md50000065296.msg; Wed, 12 Dec 2018 21:54:15 +0700
X-Spam-Flag: YES
X-Spam-Level: *****
X-Spam-Status: Yes, score=5.40 required=5.0
X-Spam-Report:
   *  1.6 BAYES_50 BODY: Bayes spam probability is 40 to 60%
   *      [score: 0.5000]
* 1.8 DRUG_ED_SILD BODY: Talks about an E.D. drug using its chemical name
   *  0.0 HTML_MESSAGE BODY: HTML included in message
   *  2.0 DRUGS_ERECTILE Refers to an erectile drug
   *  0.0 T_FILL_THIS_FORM_SHORT Fill in a short form with personal
   *      information
X-Spam-Processed: bb.ptbmi.com, Wed, 12 Dec 2018 21:54:15 +0700
   (processed during SMTP session)
X-MDOP-RefID: str=0001.0A15020A.5C112115.0077:SCGMA2348352,ss=1,re=-4.000,recu=0.000,reip=0.000,cl=1,cld=1,fgs=0 (_st=1 _vt=0 _iwf=0)
X-MDDKIM-Result: unapproved (bb.ptbmi.com)
X-MDSPF-Result: unapproved (bb.ptbmi.com)
X-MDRemoteIP: 129.145.17.215
X-MDHelo: eloquamail01.fda.gov
X-MDArrival-Date: Wed, 12 Dec 2018 21:54:15 +0700
X-Rcpt-To: [email protected]
X-MDRcpt-To: [email protected]
X-Return-Path: [email protected]
X-Envelope-From: [email protected]
X-MDaemon-Deliver-To: [email protected]
X-CAV-Result: clean
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; s=dk2016; d=info.fda.gov;
h=Message-ID:List-Unsubscribe:MIME-Version:From:To:Reply-To:Date:Subject:
Content-Type; [email protected];
bh=8C3ONNGMZdNPKr1JvFizIXJV2OsJ8Tc/Q7F0c27E5gs=;
b=0TynUUJBsdT/JYQEaRrHtx/SrHmlZNjcLVqLWp90AEm3gMt15u6yd9T4MoebEJMUijdxhYDK+L69
  lEQy3WqyOUCPEy5wXJOrTUdad6LhvZz9DkBRTU6foTiWrnwXvoz5qxElDE2S+o9Qtd/KZmnDVGxE
  QBJYISHG7QY1o5KxpUo=
Received: from G04SNJ010 (10.34.116.100) by eloquamail01.fda.gov id h24gfg2fm300 for <[email protected]>; Wed, 12 Dec 2018 09:53:08 -0500 (envelope-from <[email protected]>)
Message-ID: <30cc38a1eb0948f9893d76c8da7805d4@2027422842>
X-Binding: 2027422842
X-elqSiteID: 2027422842
X-elqPod: 0x42929D304091F2FE066CF35EC31ADF5FBC4AF91DBF6F3D6F9D91109E00869E13
X-cid: 5082-6249
List-Unsubscribe: <http://app.info.fda.gov/e/u?s=2027422842&elq=30cc38a1eb0948f9893d76c8da7805d4>
MIME-Version: 1.0
From: "U.S. Food and Drug Administration" <[email protected]>
To: [email protected]
Reply-To: "U.S. Food and Drug Administration" <[email protected]>
Date: 12 Dec 2018 09:53:17 -0500
Subject:  FDA MedWatch - Two E-Liquid Products by HelloCig Electronic
Technology Co: Warning - Contains the Undeclared Drugs
Content-Type: multipart/alternative;
boundary=--boundary_1666720_dbb35be7-afc0-4b7f-848f-bcfbde9b4e86

Diketahui:
iprev=fail policy.iprev=129.145.17.215 reason="does not match" (MAIL [email protected])

Action:
masukkan IP 129.145.17.215 ke SECURITY - DYNAMIC SCREENING - DYNAMIC WHITELIST
or
masukan [email protected] / *@info.fda.gov ke SPAM FILTER - SPAM FILTER - WHITELIST (by Sender)

Manakah yg lebih efektif?

Mohon pencerahan...

Thanks
Suzy

--
--[mdaemon-l]----------------------------------------------------------
Milis ini untuk Diskusi antar pengguna MDaemon Mail Server di Indonesia

Netiket: https://wiki.openstack.org/wiki/MailingListEtiquette
Arsip: http://mdaemon-l.dutaint.com
Dokumentasi : http://mdaemon.dutaint.co.id
Berlangganan: Kirim mail ke [email protected]
Henti Langgan: Kirim mail ke [email protected]
Versi terakhir MD 18.5.1, SG 5.5.0


Kirim email ke